Skip to main content

Radiofrequency Ablation Devices Market Trends and Forecast up to 2027

Transparency Market Research (TMR) has published a new report titled, ‘Radiofrequency Ablation Devices for Pain Management Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027.
Overview
  • Radiofrequency ablation is a minimally invasive surgical procedure that involves a local anesthetic and mild sedation. This procedure is primarily used to reduce chronic low-back and neck pain.
  • The procedure involves heating a small area of nervous tissue under controlled temperature and as a result help in blockage of pain signals transmitting from that area.
  • North America dominated the global radiofrequency ablation devices for pain management market in 2018 and the trend is anticipated to continue during the forecast period. Rise in awareness regarding the treatment benefits, high incidence rate of chronic pain among the population in the U.S. are expected to drive the market in North America.
  • However, Asia Pacific is likely to be a highly lucrative market for radiofrequency ablation devices for pain management and it is expected to expand at a high CAGR during the forecast period
Growing adoption of RF ablation for pain management among end-users to Drive Market
  • Pain leads to severe complications, if proper care or treatment is not taken for a long time. High adverse effects and lower efficiency of alternate pain relief procedures and therapeutics such as opioids, acupuncture, and acupressure has led to surge in adoption of radiofrequency ablation devices, which offer better treatment with minimal side effects.
  • Hence, high availability, easy access, increased awareness, cost-effectiveness, and quick relief provide RF ablation devices for pain management a cutting edge over other treatment options. This is likely to augment the demand for the use of radiofrequency ablation device for pain management in the market.
Disposable Products Segment to Dominate Market
  • Based on product type, the global radiofrequency ablation devices for pain management market is classified into RF generators, reusable products and disposable products. The reusable product further segmented into probes and electrodes and disposable products classified as cannulas, needles and single-use probes and electrodes.
  • Disposable cannulas and probes offers reduction in sterilization costs. Additionally, the connector cables provided for single use probes are long enough to stay out of the sterile field, thus preventing infection. Moreover, it allows temperature-controlled lesion generation procedure. This boosts demand for the disposable products.
Hospital to be Highly Lucrative Segment
  • In terms of end-user, the global radiofrequency ablation devices for pain management market has been segmented into hospitals, ambulatory surgical centers and specialty clinics.
  • The hospitals segment is expected to hold the major market share in 2018. The hospitals end-user segment is driven by increasing occurrences of chronic pain disorders especially among elderly individuals.
  • Moreover, rise in the number of patients suffering from different types of pain getting admitted to hospitals, favorable reimbursement policies, and availability of technologically advanced products in hospitals is likely to drive the segment.
North America to Dominate Global Market
  • In terms of region, the global radiofrequency ablation devices for pain management market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global radiofrequency ablation devices for pain management market in 2018, followed by Europe.
  • North America accounted for major share of the global radiofrequency ablation devices for pain management market in 2018, attributed by rise in geriatric population with chronic pain, pharmacology medication resistance and rise in awareness about the advantages of radiofrequency ablation therapy for pain management. Moreover, launch of new devices that address the unmet medical needs drive the market.
  • Key players are investing to expand their reach and strengthen their market position in North America market through new product development and approavls, in 2019, Medtronic launched its product Accurian RF system in the U.S.
Competitive Landscape
  • The global radiofrequency ablation devices for pain management market is fragmented in terms of number of players. Key players in the global market include Boston Scientific Corporation, Diros Technology, Inc., Halyard Health, Inc., Abbott, Stryker Corporation, Olympus Corporation, Merit Medical Systems, Medtronic plc, and AngioDynamic, Inc. among others among others
More Trending Reports by Transparency Market Research – Vitamin D Testing Market:

Comments

Popular posts from this blog

Angioplasty Balloons & Stents Market Research Report | Forecast Until 2027

Complications with Existing Treatments to Drive Innovations The healthcare sector is no stranger to innovations and technological advancements. Research and development activities continue to improve the efficacy of treatments and bring forward new therapies to treat a range of diseases. Over the past couple of decades, minimally invasive procedures have gained a great amount of popularity within the healthcare sector. A similar trend can be observed within the angioplasty balloons & stents market as the adoption of minimally invasive procedures is on the rise, particularly among patients who have been diagnosed with coronary heart diseases or experienced a heart attack. Request Sample Of Report –   https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5627 At present, healthcare experts are focusing on minimizing the complications involved with the percutaneous coronary intervention (PCI) by leveraging the benefits of technology that conti...

Autoimmune Disease Diagnostics Market Analysis and Forecast up to 2023

Autoimmune Disease Diagnostics Market – Snapshot When immune system attacks the body mistakenly, then the resulting condition is known as autoimmune disease. Some of the autoimmune diseases are found more commonly in certain ethnicities than others. A case in point is high prevalence of lupus amongst the Hispanic and African-American group of people rather than Caucasians. The global autoimmune disease diagnostics market is estimated to make substantial gains due to rising incidences of autoimmune diseases across the globe. Request Sample Of Report –    https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351 Some of the autoimmune diseases such as lupus and multiple sclerosis run within families. In that case, the family members will inherit vulnerability to the autoimmune illness that runs in the family but might not necessarily be affected by it. Increased Prevalence of Autoimmune Diseases to Spell Growth of the Market Many of the auto...

Analysis of COVID-19 Collagen Peptide and Gelatin Market

Collagen Peptide and Gelatin Market: Overview According to Transparency Market Research’s latest report on the global collagen peptide and gelatin market for the historical period  2017–2018  and forecast period  2019–2027 , increase in commercialization of novel collagen-based drug delivery systems and rise in social awareness about personal well-being are projected to drive the global collagen peptide and gelatin market According to the report, the global collagen peptide and gelatin market was valued at  US$ 5,976.9 Mn  in  2018  and is projected to expand at a CAGR of  8.7%  from  2019  to  2027 To know the scope of our report  Get a Sample  on Collagen Peptide and Gelatin Market Increase in social awareness about personal well-being and rigorous research and development activities in regenerative medicine and wound healing: Key Drivers Major factors driving the collagen peptide application in nutrac...